PLUS THERAPEUTICS, INC. — Director's Dealing 2017

Jan 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CTYX)
CIK: 0001095981
Period of Report: 2017-01-26

Reporting Person: MARTELL RON (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-26	Non-Qualified Stock Option (right to buy)	$1.56	A	50000	Acquired	2027-01-26	Common Stock (50000)	Direct

Footnotes

F1: The reporting person received a non-qualified stock option granted under the Issuer's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised is the closing sale price of the Issuer's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price on the date of the grant was $1.56.

F2: Fifty percent (50%) of the option shares shall vest on January 26, 2018 with the remaining fifty percent (50%) of the option shares vesting on January 26, 2019.